APA

Straus D. J., Myers J., Koziner B., Lee B. J. & Clarkson B. D. (19831217). Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). : Cancer chemotherapy and pharmacology.

Chicago

Straus D J, Myers J, Koziner B, Lee B J and Clarkson B D. 19831217. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). : Cancer chemotherapy and pharmacology.

Harvard

Straus D. J., Myers J., Koziner B., Lee B. J. and Clarkson B. D. (19831217). Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). : Cancer chemotherapy and pharmacology.

MLA

Straus D J, Myers J, Koziner B, Lee B J and Clarkson B D. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). : Cancer chemotherapy and pharmacology. 19831217.